Samsung Biologics

Related Content

Samsung enters agreement on manufacture of antibody cancer drug

Unearthing the potential of CDMO services to accelerate complex biologics development

Samsung Biologics and Pfizer's collaboration for manufacturing of biosimilars

Samsung Biologics commences construction on fifth plant

Bioprocessing in the balance: part I

Bringing performance, quality and safety to the pharmaceutical industry

Samsung Biologics earns gold rating from EcoVadis

GreenLight and Samsung complete first commercial-scale engineering run for mRNA COVID-19 vaccine

Navigating the maelstrom of M&A activity: what do CDMOs do next?

Samsung Biologics completes acquisition of Samsung Bioepis

Samsung Biologics acquires full ownership of Biogen joint venture

Samsung Biologics to manufacture AstraZeneca COVID therapy

GreenLight Biosciences and Samsung Biologics announce RNA collaboration

Driving biotherapeutic development with advanced molecule characterisation

Samsung Biologics to provide CDMO service for Enzolytics mAb therapies